Don't think unblinding SA is a priority at this moment due to the fact they want to sign a deal in the time frame specified, it may lengthen that either way- positive or negative and one party doesn't doesn't have an interest in it, .... -AMEX de-listing I failed to bring up. It was not a long conversation and I really wanted to understand the SEC share issuance request which he sufficiently explained much like either Aiming or Dew did. In his defense, I believe they are working very hard to get in a better position. I think they find it hard because they are still quite optimistic on the science and want to see thru the crisis to successful clinical studies.
Market Data 
Markets 
AI
